Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 873,97k | Derivative Exercise and Sale | 52,27 - 230,41 | 41,38k | - |
| 2026-05-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 108,25k | Automatic Disposition | 227,37 - 234,09 | 40,58k | -1,14% |
| 2026-05-12 | Dr. John Warren KozarichIndependent Chairman | -2,03k | 313,45k | Derivative Exercise and Sale | 69,51 - 224,00 | 40,58k | - |
| 2026-05-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 895,21k | Derivative Exercise and Sale | 52,27 - 234,02 | 41,38k | - |
| 2026-04-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 94,44k | Automatic Disposition | 199,97 - 204,26 | 41,04k | -1,13% |
| 2026-04-01 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 744,87k | Derivative Exercise and Sale | 52,27 - 204,50 | 41,38k | - |
| 2026-03-06 | Dr. John L. LaMattinaIndependent Director | -2,16k | 187,16k | Derivative Exercise and Sale | 114,15 - 200,76 | 29,52k | - |
| 2026-03-23 | Dr. Stephen Lawrence SabbaIndependent Director | -1.000,00 | 207,87k | Verkauf | 207,87 | 31,58k | -3,07% |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -2,41k | 318,30k | Derivative Exercise and Sale | 92,65 - 225,00 | 21,01k | - |
| 2026-03-11 | Mr. Octavio EspinozaCFO | -652,00 | 146,70k | Automatic Disposition | 225,00 | 21,01k | -3,01% |
| 2026-03-04 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -5,00k | 770,42k | Derivative Exercise and Sale | 52,27 - 208,87 | 36,87k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -2,07k | 283,93k | Derivative Exercise and Sale | 58,49 - 201,73 | 21,66k | - |
| 2026-03-04 | Mr. Octavio EspinozaCFO | -11,35k | 2,35M | Automatic Disposition | 201,73 - 208,80 | 21,66k | -34,38% |
| 2026-03-03 | Dr. Stephen Lawrence SabbaIndependent Director | -2,03k | 268,47k | Derivative Exercise and Sale | 69,51 - 201,50 | 32,58k | - |
| 2026-03-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 93,63k | Automatic Disposition | 197,14 - 203,57 | 41,51k | -1,11% |
| 2026-02-14 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -9,68k | 1,78M | Sale to Issuer | 183,83 | 36,87k | -20,80% |
| 2026-02-14 | Mr. Octavio EspinozaCFO | -11,76k | 2,16M | Sale to Issuer | 183,83 | 33,01k | -26,27% |
| 2026-02-14 | Mr. Todd C. DavisCEO & Director | -32,88k | 6,04M | Sale to Issuer | 183,83 | 163,82k | -16,71% |
| 2026-02-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 91,49k | Automatic Disposition | 191,00 - 197,20 | 41,98k | -1,10% |
| 2026-01-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 88,53k | Automatic Disposition | 186,59 - 192,40 | 42,45k | -1,09% |
| 2025-12-16 | Mr. Octavio EspinozaCFO | 2,38k | 164,30k | Derivative Exercise and Retained Stock | 52,84 - 103,42 | 28,57k | 9,09% |
| 2025-12-12 | Mr. Octavio EspinozaCFO | -1,80k | 339,71k | Verkauf | 188,31 | 26,19k | -6,45% |
| 2025-12-05 | Mr. Octavio EspinozaCFO | -1,86k | 344,23k | Sale to Issuer | 184,87 | 27,99k | -6,24% |
| 2025-12-04 | Mr. Todd C. DavisCEO & Director | -130,00 | 0,00 | Other Disposition | - | 112,66k | -0,12% |
| 2025-12-08 | Mr. Jason M. AryehIndependent Director | 2,03k | 141,38k | Derivative Exercise and Retained Stock | 69,51 | 75,14k | 2,78% |
| 2025-12-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 91,46k | Automatic Disposition | 193,86 - 200,02 | 42,91k | -1,08% |
| 2025-11-07 | Dr. John L. LaMattinaIndependent Director | -4,18k | 575,34k | Derivative Exercise and Sale | 66,13 - 205,45 | 29,52k | - |
| 2025-11-07 | Dr. Nancy Ryan GrayIndependent Director | -6,57k | 892,83k | Derivative Exercise and Sale | 66,19 - 205,45 | 6,89k | - |
| 2025-11-03 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 89,22k | Automatic Disposition | 189,00 - 192,38 | 43,38k | -1,07% |
| 2025-10-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 83,80k | Automatic Disposition | 177,60 - 181,18 | 43,85k | -1,05% |
| 2025-09-22 | Dr. Martine ZimmermannIndependent Director | -115,00 | 19,64k | Sale to Issuer | 170,77 | - | - |
| 2025-09-23 | Mr. Jason M. AryehIndependent Director | -10,00k | 1,71M | Verkauf | 170,41 - 171,92 | 73,11k | -12,03% |
| 2025-09-02 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 75,77k | Automatic Disposition | 161,51 - 164,25 | 44,31k | -1,04% |
| 2025-08-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -1,33k | 198,83k | Sale to Issuer | 150,06 | 30,81k | -4,12% |
| 2025-08-01 | Dr. John Warren KozarichIndependent Chairman | -467,00 | 61,59k | Automatic Disposition | 131,88 | 44,78k | -1,03% |
| 2025-07-10 | Dr. John Warren KozarichIndependent Chairman | -934,00 | 116,75k | Automatic Disposition | 125,00 | 45,25k | -2,02% |
| 2025-06-23 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500,00 | 57,04k | Verkauf | 114,08 | 31,90k | -1,54% |
| 2025-06-10 | Mr. Andrew T. ReardonChief Legal Officer & Secretary | -500,00 | 57,27k | Verkauf | 114,54 | 32,40k | -1,52% |
| 2025-06-06 | Dr. Martine ZimmermannIndependent Director | -188,00 | 19,93k | Sale to Issuer | 105,99 | - | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
